Kunming Dianchi Water Treatment Full Year 2024 Earnings: EPS: CN¥0.26 (vs CN¥0.31 in FY 2023)

Simply Wall St

April 28, 2025

Kunming Dianchi Water Treatment (HKG:3768) Full Year 2024 Results

Key Financial Results

Revenue: CN¥1.59b (down 12% from FY 2023).
Net income: CN¥263.2m (down 17% from FY 2023).
Profit margin: 17% (in line with FY 2023).
EPS: CN¥0.26 (down from CN¥0.31 in FY 2023).

Our free stock report includes 3 warning signs investors should be aware of before investing in Kunming Dianchi Water Treatment. Read for free now.

revenue-and-expenses-breakdown — SEHK:3768 Revenue and Expenses Breakdown April 28th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Wastewater Treatment segment contributing a total revenue of CN¥1.15b (72% of total revenue). Notably, cost of sales worth CN¥880.5m amounted to 55% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling CN¥265.4m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how 3768's revenue and expenses shape its earnings.

Kunming Dianchi Water Treatment shares are up 5.5% from a week ago.

Risk Analysis

Be aware that Kunming Dianchi Water Treatment is showing 3 warning signs in our investment analysis and 2 of those make us uncomfortable...

Valuation is complex, but we're here to simplify it.

Discover if Kunming Dianchi Water Treatment might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.